Immuno-Suppressive Drugs May Not Increase Risk of COVID-19:
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
A group of researchers claim that people who are on immunosuppressants for common skin and rheumatic conditions including rheumatoid arthritis and psoriasis are not at an increased risk of getting COVID-19 and should continue to take the medications, according to a study published in the Journal of the American Academy of Dermatology.


• For the study, the researchers did a retrospective cohort analysis of patients at the Henry Ford Healthcare System who tested positive for COVID-19 between 1 February and 18 April 2020.

• About 213 patients with immune-mediated inflammatory diseases (IMID) were included in the study. Out of these about 36.2 % tested positive for COVID-19.


• 36.2% patients who had tested positive for COVID-19 did not show any higher risk of hospitalisation or need for ventilation.

• Those who were taking prescribed TNF alpha inhibitors had a lower chance of hospitalisation.

• Those who were on single-drug treatment did not have a high risk of getting COVID-19 or developing a severe condition.

• However, those on multiple-drug therapy were at a higher risk of getting hospitalised.

Previous evidence: Those who are taking immunosuppressive drugs were intuitively included under the high-risk category for COVID-19 along with people with weak immunity, the elderly and those with chronic conditions. However, in the absence of clinical evidence, scientists have since been dubious about this recommendation.

Dr. T●●●●z H●●●●●●i and 1 others like this2 shares